Table 1 Summary of the clinical and histological data of 18 patients with primary and recurrent gliomas
From: Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas
Case | Age (y) | Sex | Site of tumor | Interval of biopsies (m) | Survival (m) | Histology P/R | Adjuvant therapy |
|---|---|---|---|---|---|---|---|
1 | 20 | M | RTL | 15 | ALIVE | PA2 | R |
RTL | RA3 | - | |||||
2 | 48 | M | LTL | 24 | ALIVE | PA2 | R |
LTL | RA3 | - | |||||
3 | 55 | M | RFL | 13 | 14 | PA3 | - |
RFL | RA3 | - | |||||
4 | 50 | F | LTL | 74 | ALIVE | PA2 | R |
LTL | RA3 | T | |||||
5 | 30 | M | RFL | 662 | ALIVE | PA2 | R |
RFL | RA3 | - | |||||
6 | 41 | F | RTL | 42 | 64 | PA2 | R |
RTL | RA3 | - | |||||
7 | 50 | M | LOL | 9 | 18 | PA3 | R |
LOL | RGB | T | |||||
8 | 15 | F | LFL | 31 | 49 | PA3 | R |
LFL | RGB | CVP | |||||
9 | 27 | F | RFL | 33 | 98 | PA3 | R |
RFL | RGB | T | |||||
10 | 56 | F | RPL | 12 | 32 | PA3 | R |
RPL | RGB | - | |||||
11 | 69 | F | RFL | 11 | 16 | PGB | R |
RFL | RGB | - | |||||
12 | 44 | M | LPL | 3 | 6 | PGB | R |
LPL | RGB | - | |||||
13 | 47 | M | LFL | 9 | 12 | PGB | - |
LFL | RGB | T | |||||
14 | 55 | M | LTL | 13 | 19 | PGB | R |
LTL | RGB | T | |||||
15 | 62 | M | RFL | 6 | 18 | PGB | R |
RFL | RGB | T | |||||
16 | 54 | M | RTL | 12 | 14 | PGB | R |
RTL | RGB | T | |||||
17 | 41 | M | RTL | 10 | 24 | PGCGB | R |
RTL | RGCGB | T | |||||
18 | 17 | F | RTL | 15 | 29 | PGCGB | R |
RTL | RGCGB | CVP |